Direct to Patient Survey to Examine Treatment Satisfaction and Experience With Dapagliflozin Compared to Sulfonylureas
Phase of Trial: Phase IV
Latest Information Update: 06 Sep 2017
At a glance
- Drugs Dapagliflozin (Primary) ; Dapagliflozin/metformin (Primary) ; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 30 Aug 2017 Planned End Date changed from 31 Dec 2017 to 31 Jul 2018.
- 30 Aug 2017 Planned primary completion date changed from 31 Dec 2017 to 31 Jul 2018.
- 14 Jul 2016 Status changed from not yet recruiting to recruiting.